Edward Hejlek
Corporate Officer/Principal bei ENOVIX CORPORATION
Vermögen: 1 Mio $ am 30.04.2024
Profil
Edward J.
Hejlek is currently the Senior Vice President-Intellectual Property at Enovix Corp.
He previously worked as the Executive Vice President & General Counsel at Tricida, Inc. from 2019 to 2020.
Prior to that, he was a Partner at Bryan Cave Leighton Paisner LLP from 2008 to 2015.
He also served as Counsel at Ilypsa, Inc. from 2005 to 2008 and at Relypsa, Inc. from 2007 to 2008.
He started his career as a Partner & Attorney at Senniger Powers LLP from 1986 to 2008.
Mr. Hejlek obtained his undergraduate degree from the University of Washington and his graduate degree from the University of Missouri.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENOVIX CORPORATION
0,12% | 02.04.2023 | 208 634 ( 0,12% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Edward Hejlek
| Unternehmen | Position | Beginn |
|---|---|---|
| ENOVIX CORPORATION | Corporate Officer/Principal | 14.11.2022 |
Ehemalige bekannte Positionen von Edward Hejlek
| Unternehmen | Position | Ende |
|---|---|---|
Bryan Cave Leighton Paisner LLP
 Bryan Cave Leighton Paisner LLP Miscellaneous Commercial ServicesCommercial Services Bryan Cave Leighton Paisner LLP provides legal services. It is a business and litigation firm with a diverse client base, includes business, financial institutions and not-for-profit organizations, government entities and individual clients. The firm represents business, financial, institutional and individual clients, including publicly held multinational corporations, large and mid-sized privately held companies, partnerships and emerging companies. The company was founded by Robert D. Klingler in 1873 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | 01.12.2015 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | General Counsel | 01.03.2008 |
| RELYPSA INC | General Counsel | 01.03.2008 |
Senniger Powers LLP
 Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Senniger Powers LLP provides legal services. It offers pro bono services, patents, and litigation services. The company is headquartered in St. Louis, MO. | Corporate Officer/Principal | 01.03.2008 |
| TRICIDA, INC. | General Counsel | 09.03.2020 |
Ausbildung von Edward Hejlek
| University of Washington | Undergraduate Degree |
| University of Missouri | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TRICIDA, INC. | Health Technology |
| ENOVIX CORPORATION | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Bryan Cave Leighton Paisner LLP
Bryan Cave Leighton Paisner LLP Miscellaneous Commercial ServicesCommercial Services Bryan Cave Leighton Paisner LLP provides legal services. It is a business and litigation firm with a diverse client base, includes business, financial institutions and not-for-profit organizations, government entities and individual clients. The firm represents business, financial, institutional and individual clients, including publicly held multinational corporations, large and mid-sized privately held companies, partnerships and emerging companies. The company was founded by Robert D. Klingler in 1873 and is headquartered in St. Louis, MO. | Commercial Services |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Senniger Powers LLP
Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Senniger Powers LLP provides legal services. It offers pro bono services, patents, and litigation services. The company is headquartered in St. Louis, MO. | Commercial Services |
